Table 1.
Demographic data and surgery details in the LMA and ETI groups.
| LMA group (n = 40) | ETI group (n = 40) | |
|---|---|---|
| Age (years) | 40.8 ± 10.6 | 44.4 ± 13.2 |
| Sex (M/F) | 17/23 | 18/22 |
| BMI (kg/m2) | 23.4 ± 3.1 | 24.4 ± 3.4 |
| Tumor types (glioma/meningioma/others) | 15/14/11 | 15/14/11 |
| Dose of sufentanil (µg) | 79.5 ± 20.8 | 105.3 ± 30.9 |
| Infusion amount (mL) | 3057.5 ± 756.3 | 3294.4 ± 610.1 |
| Urine amount (mL) | 1230.0 ± 530.7 | 1480.0 ± 737.4 |
| Blood loss (mL) | 326.3 ± 160.1 | 352.5 ± 141.9 |
| Application of vasoactive drug (cases) (esmolol/nicardipine) | 2/0 | 9/0 |
| Duration of anesthesia (minutes) | 247.9 ± 78.8 | 271.1 ± 43.5 |
| Duration of hospitalization (day) | 16.0 ± 6.4 | 17.9 ± 7.6 |
LMA, laryngeal mask; ETI, endotracheal intubation; BMI, body mass index.